reference/8859706

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8859706

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
issn	2059-3635 2095-9907
issueIdentifier	1
pageRange	140-
publicationName	Signal Transduction and Targeted Therapy
startingPage	140
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_31f2a543be149aa96cca75fad1a1e988
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b07b944818ee63e8caf7b074fe20c0d6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a6f7be10362d14804b4b97456633d99c
bibliographicCitation	Rehmani H, Li Y, Li T, Padia R, Calbay O, Jin L, Chen H, Huang S. Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer. Signal Transduction and Targeted Therapy. 2020 Aug 21;5(1):140. doi: 10.1038/s41392-020-0197-8.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c312fda2e2ed0c6c8e561a385c842ba0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b79004852c791b2dffd64a2f00a805b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_343469a9156256dcea2c3f6ce0c58261 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f537d573c24e945947eb54f062fdc02 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2252-8976 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2b012f7432332c26ecf479401ea79e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17002ad2a6cbf453c41041c450c8e48c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_047e3b8762d1937fafa396dad08db9dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c872f8f6082b5aacc9bf8f32855ef96f
date	2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41392-020-0197-8 https://pubmed.ncbi.nlm.nih.gov/PMC7441162 https://pubmed.ncbi.nlm.nih.gov/32820156
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44885 https://portal.issn.org/resource/ISSN/2059-3635 https://portal.issn.org/resource/ISSN/2095-9907
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer
discusses	http://id.nlm.nih.gov/mesh/M0230752 http://id.nlm.nih.gov/mesh/M0483498 http://id.nlm.nih.gov/mesh/M0011758 http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0017861
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e85cb66a7d574b9e02005c94576b0ac0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b77e41c8d2fcc93d222a4b7c254e1d72 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6629 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4cec3077c592ef6f6bdb898ae445baab http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5584

Total number of triples: 46.